Advertisement
Arcellx, Inc.

Arcellx, Inc. (ACLX) Stock Overview

Explore Arcellx, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACLX●NASDAQ
HealthcareBiotechnology
$115.07
$0.02(0.02%)
U.S. Market opens in 16h 8m
Advertisement

Arcellx, Inc. (ACLX)

Meyka AI Score

Z

Key Financials

Market Cap6.7B
P/E Ratio-28.30
EPS (TTM)$-4.07
ROE-0.55%
Fundamental Analysis

AI Price Forecasts

1 Month$114.17
3 Months$61.62
1 Year Target$95.74

ACLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Arcellx, Inc. (ACLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.98, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $95.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.30 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
0.67%
6-Month Change
68.11%
Year-to-Date (YTD) Change
76.49%
1-Year Change
75.73%
3-Year Change
180.66%
5-Year Change
584.94%
All-Time (Max) Change
584.94%

Contact Information

https://arcellx.com
240 327 0603
25 West Watkins Mill Road, Redwood City, MD, 20878

Company Facts

1,630 Employees
IPO DateFeb 4, 2022
CountryUS

Frequently Asked Questions